New hope for advanced bladder cancer: BISCAY trial tests multiple drug combos
NCT ID NCT02546661
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with muscle-invasive bladder cancer that has gotten worse after earlier treatments. It tests several different drug combinations, chosen based on the specific genetic markers of each person's tumor. The main goal is to see if these combinations are safe and tolerable, and to gather early information on how well they work.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Los Angeles, California, 90095, United States
-
Research Site
New Haven, Connecticut, 06510, United States
-
Research Site
Fort Myers, Florida, 33901, United States
-
Research Site
New York, New York, 10029, United States
-
Research Site
New York, New York, 10032, United States
-
Research Site
New York, New York, 10116, United States
-
Research Site
Cleveland, Ohio, 44195, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Edmonton, Alberta, T6G 1Z2, Canada
-
Research Site
Vancouver, British Columbia, V5Z 4E6, Canada
-
Research Site
Toronto, Ontario, M5G 2M9, Canada
-
Research Site
Montreal, Quebec, H3T 1E2, Canada
-
Research Site
Bordeaux, 33075, France
-
Research Site
Caen, 14000, France
-
Research Site
Lyon, 69373, France
-
Research Site
Marseille, 13273, France
-
Research Site
Saint-Herblain, 44805, France
-
Research Site
Toulouse, 31100, France
-
Research Site
Badalona, 08003, Spain
-
Research Site
Barcelona, 08035, Spain
-
Research Site
Barcelona, 08041, Spain
-
Research Site
Madrid, 28040, Spain
-
Research Site
Glasgow, G12 0YN, United Kingdom
-
Research Site
London, EC1M 6BQ, United Kingdom
-
Research Site
London, W1G 6AD, United Kingdom
-
Research Site
Manchester, M20 4BX, United Kingdom
-
Research Site
Southampton, SO16 6YD, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Bladder cancer: a new combo aims to avoid radical surgery
- Can a special PET scan see bladder cancer more clearly?
- Bladder cancer surgery: what happens after the bladder is removed?
- Lab-Grown tumor clusters guide tailored bladder cancer therapy
- Experimental immunotherapy targets tough urinary cancers